Navigation Links
Professor K. C. Nicolaou Speaks at WuXi AppTec
Date:3/17/2009

SHANGHAI, March 17 /PRNewswire-Asia/ -- WuXi AppTec is honored to have Prof. K. C. Nicolaou, the leading authority of the world on natural product total synthesis, as a WuXi AppTec Science Seminar Series lecturer to share his experience and expertise with our company's scientists today. Total Synthesis is a process of creating complex organic molecules from simpler compounds.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

The WuXi AppTec Science Seminar Series is a monthly program that invites the world's top scientific minds and leaders in the pharmaceutical industry to speak with our company's scientists. The program aims to keep them informed about the latest developments in a broad range of topics in pharmaceutical research and development.

Dr. Nicolaou received his Ph.D. from University College London in 1972. From 1972 to 1976, he conducted postdoctoral research, first under Professor T.J. Katz of Columbia University and later under Professor E.J. Corey of Harvard University. He then joined the faculty at the University of Pennsylvania, where he became the Rhodes-Thompson Professor of Chemistry. In 1989, he accepted joint appointments at the University of California, San Diego, where he is Professor of Chemistry, and at the Scripps Research Institute, where he is the Chairman of the Department of Chemistry and holds the Skaggs Professorship of Chemical Biology and the Darlene Shiley Chair in Chemistry.

Dr. Nicolaou is a member of the New York Academy of Sciences, a fellow of the American Academy of Arts and Sciences, a member of the National Academy of Sciences, a fellow of the American Association for the Advancement of Science, and a foreign member of the Academy of Athens. He holds numerous honorary degrees from leading universities. He is author or co-author of more than 60 patents, more than 675 publications, and four books, including textbooks on total synthesis.

"I'm especially pleased to have Dr. Nicolaou here in Shanghai to share his knowledge of organic synthesis," said Dr. Ge Li, Chairman and Chief Executive Officer of WuXi AppTec. "WuXi AppTec is one of the largest employers of synthetic chemists in the world. We will apply the messages in his lecture to our efforts to produce bioactive molecules for the world's leading pharmaceutical companies."

About WuXi AppTec and WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec. For more information, please visit: http://www.wuxiapptec.com .

    For more information, please contact:

     Sherry Shao
     WuXi PharmaTech (Cayman) Inc.
     Tel:   +86-21-5046-4002
     Email: pr@wuxiapptec.com

'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Nyenrode Honorary Doctorate for Professor Michael E. Porter
2. Thin films research lands engineering professor Air Force Young Investigator Award
3. Gift Aids Professor's Research into Vein Treatment
4. Kiadis Pharma Announces Continued Collaboration With Professor Velardi on its Lead Product ATIR(TM)
5. UCF professor develops vaccine to protect against black plague bioterror attack
6. Yale professor T.P. Ma awarded the Connecticut Medal of Technology
7. Stuart Parkin first distinguished professor at Eindhoven University of Technology
8. UCF professor develops vaccine to protect against black plague bioterror attack
9. Professor-turned-producer learns the movie biz
10. Professors Marc Feldmann and Sir Ravinder Maini Named Winners of the 2008 Dr. Paul Janssen Award for Biomedical Research
11. Professor Toh-Ming Lu named fellow of the Materials Research Society
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... NEW YORK , June 22, 2016 /PRNewswire/ ... the growing next generation sequencing (NGS) market include ... adoption of smaller sequencers.  More accessible and affordable ... led to growing demand for consumables including sample ... The Market for Sample Preparation for Next ...
(Date:6/22/2016)... , June 22, 2016   ViaCyte, Inc. , ... stem cell-derived islet replacement therapy for the treatment of ... ISSCR 2016 Annual Meeting.  ISSCR 2016, the Global Stem ... at Moscone West in San Francisco.  ... presentations are as follows:Event: , Focus Session: Tools for ...
(Date:6/22/2016)... 2016  Mesa Biotech Inc., a privately-held, molecular ... designed specifically for point-of-care (POC) infectious disease diagnosis, ... board (SAB). Approved by the executive leadership team ... to advise on the development and commercialization of ... Dr. Steve Young , this world-class team ...
(Date:6/21/2016)... NANJING , China , June ... that a Phase 2 clinical trial for its novel ... statistically significant (p=0.023) and clinically meaningful pain relief against ... the United States , the trial enrolled 146 ... statistically significant (1) analgesia against placebo at week-1 (p=0.024), ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... -- A new partnership announced today will help life ... a fraction of the time it takes today, ... insurance policies to consumers without requiring inconvenient and ... rapid testing (A1C, Cotinine and HIV) and higi,s ... pulse, BMI, and activity data) available at local ...
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
Breaking Biology News(10 mins):